Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 99

Published Date: 23 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Microneedle Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.

This report studies the global Microneedle Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Microneedle Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Microneedle Flu Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Microneedle Flu Vaccine total production and demand, 2018-2029, (K Dose)
Global Microneedle Flu Vaccine total production value, 2018-2029, (USD Million)
Global Microneedle Flu Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Microneedle Flu Vaccine consumption by region & country, CAGR, 2018-2029 & (K Dose)
U.S. VS China: Microneedle Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Microneedle Flu Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Dose)
Global Microneedle Flu Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Microneedle Flu Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
This reports profiles key players in the global Microneedle Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals and Microdermics and OraSure Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Microneedle Flu Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Microneedle Flu Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Microneedle Flu Vaccine Market, Segmentation by Type
    Solid Microneedle
    Hollow Microneedle
    Coated Microneedle
    Dissolving Microneedle

Global Microneedle Flu Vaccine Market, Segmentation by Application
    Influenza A
    Influenza B

Companies Profiled:
    Sanofi
    GC Pharma
    Debiotech
    NanoPass Technologies
    Corium International
    Becton Dickinson and Company
    FluGen
    CosMED Pharmaceuticals
    Microdermics and OraSure Technologies

Key Questions Answered
1. How big is the global Microneedle Flu Vaccine market?
2. What is the demand of the global Microneedle Flu Vaccine market?
3. What is the year over year growth of the global Microneedle Flu Vaccine market?
4. What is the production and production value of the global Microneedle Flu Vaccine market?
5. Who are the key producers in the global Microneedle Flu Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Microneedle Flu Vaccine Introduction
    1.2 World Microneedle Flu Vaccine Supply & Forecast
        1.2.1 World Microneedle Flu Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Microneedle Flu Vaccine Production (2018-2029)
        1.2.3 World Microneedle Flu Vaccine Pricing Trends (2018-2029)
    1.3 World Microneedle Flu Vaccine Production by Region (Based on Production Site)
        1.3.1 World Microneedle Flu Vaccine Production Value by Region (2018-2029)
        1.3.2 World Microneedle Flu Vaccine Production by Region (2018-2029)
        1.3.3 World Microneedle Flu Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Microneedle Flu Vaccine Production (2018-2029)
        1.3.5 Europe Microneedle Flu Vaccine Production (2018-2029)
        1.3.6 China Microneedle Flu Vaccine Production (2018-2029)
        1.3.7 Japan Microneedle Flu Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Microneedle Flu Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Microneedle Flu Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Microneedle Flu Vaccine Demand (2018-2029)
    2.2 World Microneedle Flu Vaccine Consumption by Region
        2.2.1 World Microneedle Flu Vaccine Consumption by Region (2018-2023)
        2.2.2 World Microneedle Flu Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Microneedle Flu Vaccine Consumption (2018-2029)
    2.4 China Microneedle Flu Vaccine Consumption (2018-2029)
    2.5 Europe Microneedle Flu Vaccine Consumption (2018-2029)
    2.6 Japan Microneedle Flu Vaccine Consumption (2018-2029)
    2.7 South Korea Microneedle Flu Vaccine Consumption (2018-2029)
    2.8 ASEAN Microneedle Flu Vaccine Consumption (2018-2029)
    2.9 India Microneedle Flu Vaccine Consumption (2018-2029)

3 World Microneedle Flu Vaccine Manufacturers Competitive Analysis
    3.1 World Microneedle Flu Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Microneedle Flu Vaccine Production by Manufacturer (2018-2023)
    3.3 World Microneedle Flu Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Microneedle Flu Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Microneedle Flu Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Microneedle Flu Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Microneedle Flu Vaccine in 2022
    3.6 Microneedle Flu Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Microneedle Flu Vaccine Market: Region Footprint
        3.6.2 Microneedle Flu Vaccine Market: Company Product Type Footprint
        3.6.3 Microneedle Flu Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Microneedle Flu Vaccine Production Value Comparison
        4.1.1 United States VS China: Microneedle Flu Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Microneedle Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Microneedle Flu Vaccine Production Comparison
        4.2.1 United States VS China: Microneedle Flu Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Microneedle Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Microneedle Flu Vaccine Consumption Comparison
        4.3.1 United States VS China: Microneedle Flu Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Microneedle Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Microneedle Flu Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Microneedle Flu Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Microneedle Flu Vaccine Production (2018-2023)
    4.5 China Based Microneedle Flu Vaccine Manufacturers and Market Share
        4.5.1 China Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Microneedle Flu Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Microneedle Flu Vaccine Production (2018-2023)
    4.6 Rest of World Based Microneedle Flu Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Microneedle Flu Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Microneedle Flu Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Microneedle Flu Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Solid Microneedle
        5.2.2 Hollow Microneedle
        5.2.3 Coated Microneedle
        5.2.4 Dissolving Microneedle
    5.3 Market Segment by Type
        5.3.1 World Microneedle Flu Vaccine Production by Type (2018-2029)
        5.3.2 World Microneedle Flu Vaccine Production Value by Type (2018-2029)
        5.3.3 World Microneedle Flu Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Microneedle Flu Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Influenza A
        6.2.2 Influenza B
    6.3 Market Segment by Application
        6.3.1 World Microneedle Flu Vaccine Production by Application (2018-2029)
        6.3.2 World Microneedle Flu Vaccine Production Value by Application (2018-2029)
        6.3.3 World Microneedle Flu Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Microneedle Flu Vaccine Product and Services
        7.1.4 Sanofi Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 GC Pharma
        7.2.1 GC Pharma Details
        7.2.2 GC Pharma Major Business
        7.2.3 GC Pharma Microneedle Flu Vaccine Product and Services
        7.2.4 GC Pharma Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 GC Pharma Recent Developments/Updates
        7.2.6 GC Pharma Competitive Strengths & Weaknesses
    7.3 Debiotech
        7.3.1 Debiotech Details
        7.3.2 Debiotech Major Business
        7.3.3 Debiotech Microneedle Flu Vaccine Product and Services
        7.3.4 Debiotech Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Debiotech Recent Developments/Updates
        7.3.6 Debiotech Competitive Strengths & Weaknesses
    7.4 NanoPass Technologies
        7.4.1 NanoPass Technologies Details
        7.4.2 NanoPass Technologies Major Business
        7.4.3 NanoPass Technologies Microneedle Flu Vaccine Product and Services
        7.4.4 NanoPass Technologies Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 NanoPass Technologies Recent Developments/Updates
        7.4.6 NanoPass Technologies Competitive Strengths & Weaknesses
    7.5 Corium International
        7.5.1 Corium International Details
        7.5.2 Corium International Major Business
        7.5.3 Corium International Microneedle Flu Vaccine Product and Services
        7.5.4 Corium International Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Corium International Recent Developments/Updates
        7.5.6 Corium International Competitive Strengths & Weaknesses
    7.6 Becton Dickinson and Company
        7.6.1 Becton Dickinson and Company Details
        7.6.2 Becton Dickinson and Company Major Business
        7.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
        7.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Becton Dickinson and Company Recent Developments/Updates
        7.6.6 Becton Dickinson and Company Competitive Strengths & Weaknesses
    7.7 FluGen
        7.7.1 FluGen Details
        7.7.2 FluGen Major Business
        7.7.3 FluGen Microneedle Flu Vaccine Product and Services
        7.7.4 FluGen Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 FluGen Recent Developments/Updates
        7.7.6 FluGen Competitive Strengths & Weaknesses
    7.8 CosMED Pharmaceuticals
        7.8.1 CosMED Pharmaceuticals Details
        7.8.2 CosMED Pharmaceuticals Major Business
        7.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
        7.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 CosMED Pharmaceuticals Recent Developments/Updates
        7.8.6 CosMED Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Microdermics and OraSure Technologies
        7.9.1 Microdermics and OraSure Technologies Details
        7.9.2 Microdermics and OraSure Technologies Major Business
        7.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
        7.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Microdermics and OraSure Technologies Recent Developments/Updates
        7.9.6 Microdermics and OraSure Technologies Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Microneedle Flu Vaccine Industry Chain
    8.2 Microneedle Flu Vaccine Upstream Analysis
        8.2.1 Microneedle Flu Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Microneedle Flu Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Microneedle Flu Vaccine Production Mode
    8.6 Microneedle Flu Vaccine Procurement Model
    8.7 Microneedle Flu Vaccine Industry Sales Model and Sales Channels
        8.7.1 Microneedle Flu Vaccine Sales Model
        8.7.2 Microneedle Flu Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Microneedle Flu Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Microneedle Flu Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Microneedle Flu Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Microneedle Flu Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Microneedle Flu Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Microneedle Flu Vaccine Production by Region (2018-2023) & (K Dose)
    Table 7. World Microneedle Flu Vaccine Production by Region (2024-2029) & (K Dose)
    Table 8. World Microneedle Flu Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Microneedle Flu Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Microneedle Flu Vaccine Average Price by Region (2018-2023) & (US$/Dose)
    Table 11. World Microneedle Flu Vaccine Average Price by Region (2024-2029) & (US$/Dose)
    Table 12. Microneedle Flu Vaccine Major Market Trends
    Table 13. World Microneedle Flu Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Dose)
    Table 14. World Microneedle Flu Vaccine Consumption by Region (2018-2023) & (K Dose)
    Table 15. World Microneedle Flu Vaccine Consumption Forecast by Region (2024-2029) & (K Dose)
    Table 16. World Microneedle Flu Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Microneedle Flu Vaccine Producers in 2022
    Table 18. World Microneedle Flu Vaccine Production by Manufacturer (2018-2023) & (K Dose)
    Table 19. Production Market Share of Key Microneedle Flu Vaccine Producers in 2022
    Table 20. World Microneedle Flu Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 21. Global Microneedle Flu Vaccine Company Evaluation Quadrant
    Table 22. World Microneedle Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Microneedle Flu Vaccine Production Site of Key Manufacturer
    Table 24. Microneedle Flu Vaccine Market: Company Product Type Footprint
    Table 25. Microneedle Flu Vaccine Market: Company Product Application Footprint
    Table 26. Microneedle Flu Vaccine Competitive Factors
    Table 27. Microneedle Flu Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Microneedle Flu Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Microneedle Flu Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Microneedle Flu Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 31. United States VS China Microneedle Flu Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 32. United States Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Microneedle Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Microneedle Flu Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Microneedle Flu Vaccine Production (2018-2023) & (K Dose)
    Table 36. United States Based Manufacturers Microneedle Flu Vaccine Production Market Share (2018-2023)
    Table 37. China Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Microneedle Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Microneedle Flu Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Microneedle Flu Vaccine Production (2018-2023) & (K Dose)
    Table 41. China Based Manufacturers Microneedle Flu Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Microneedle Flu Vaccine Production (2018-2023) & (K Dose)
    Table 46. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Market Share (2018-2023)
    Table 47. World Microneedle Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Microneedle Flu Vaccine Production by Type (2018-2023) & (K Dose)
    Table 49. World Microneedle Flu Vaccine Production by Type (2024-2029) & (K Dose)
    Table 50. World Microneedle Flu Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Microneedle Flu Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Microneedle Flu Vaccine Average Price by Type (2018-2023) & (US$/Dose)
    Table 53. World Microneedle Flu Vaccine Average Price by Type (2024-2029) & (US$/Dose)
    Table 54. World Microneedle Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Microneedle Flu Vaccine Production by Application (2018-2023) & (K Dose)
    Table 56. World Microneedle Flu Vaccine Production by Application (2024-2029) & (K Dose)
    Table 57. World Microneedle Flu Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Microneedle Flu Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Microneedle Flu Vaccine Average Price by Application (2018-2023) & (US$/Dose)
    Table 60. World Microneedle Flu Vaccine Average Price by Application (2024-2029) & (US$/Dose)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Microneedle Flu Vaccine Product and Services
    Table 64. Sanofi Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. GC Pharma Basic Information, Manufacturing Base and Competitors
    Table 68. GC Pharma Major Business
    Table 69. GC Pharma Microneedle Flu Vaccine Product and Services
    Table 70. GC Pharma Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. GC Pharma Recent Developments/Updates
    Table 72. GC Pharma Competitive Strengths & Weaknesses
    Table 73. Debiotech Basic Information, Manufacturing Base and Competitors
    Table 74. Debiotech Major Business
    Table 75. Debiotech Microneedle Flu Vaccine Product and Services
    Table 76. Debiotech Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Debiotech Recent Developments/Updates
    Table 78. Debiotech Competitive Strengths & Weaknesses
    Table 79. NanoPass Technologies Basic Information, Manufacturing Base and Competitors
    Table 80. NanoPass Technologies Major Business
    Table 81. NanoPass Technologies Microneedle Flu Vaccine Product and Services
    Table 82. NanoPass Technologies Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. NanoPass Technologies Recent Developments/Updates
    Table 84. NanoPass Technologies Competitive Strengths & Weaknesses
    Table 85. Corium International Basic Information, Manufacturing Base and Competitors
    Table 86. Corium International Major Business
    Table 87. Corium International Microneedle Flu Vaccine Product and Services
    Table 88. Corium International Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Corium International Recent Developments/Updates
    Table 90. Corium International Competitive Strengths & Weaknesses
    Table 91. Becton Dickinson and Company Basic Information, Manufacturing Base and Competitors
    Table 92. Becton Dickinson and Company Major Business
    Table 93. Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
    Table 94. Becton Dickinson and Company Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Becton Dickinson and Company Recent Developments/Updates
    Table 96. Becton Dickinson and Company Competitive Strengths & Weaknesses
    Table 97. FluGen Basic Information, Manufacturing Base and Competitors
    Table 98. FluGen Major Business
    Table 99. FluGen Microneedle Flu Vaccine Product and Services
    Table 100. FluGen Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. FluGen Recent Developments/Updates
    Table 102. FluGen Competitive Strengths & Weaknesses
    Table 103. CosMED Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 104. CosMED Pharmaceuticals Major Business
    Table 105. CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
    Table 106. CosMED Pharmaceuticals Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. CosMED Pharmaceuticals Recent Developments/Updates
    Table 108. Microdermics and OraSure Technologies Basic Information, Manufacturing Base and Competitors
    Table 109. Microdermics and OraSure Technologies Major Business
    Table 110. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
    Table 111. Microdermics and OraSure Technologies Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 112. Global Key Players of Microneedle Flu Vaccine Upstream (Raw Materials)
    Table 113. Microneedle Flu Vaccine Typical Customers
    Table 114. Microneedle Flu Vaccine Typical Distributors
List of Figure
    Figure 1. Microneedle Flu Vaccine Picture
    Figure 2. World Microneedle Flu Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Microneedle Flu Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Microneedle Flu Vaccine Production (2018-2029) & (K Dose)
    Figure 5. World Microneedle Flu Vaccine Average Price (2018-2029) & (US$/Dose)
    Figure 6. World Microneedle Flu Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Microneedle Flu Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Microneedle Flu Vaccine Production (2018-2029) & (K Dose)
    Figure 9. Europe Microneedle Flu Vaccine Production (2018-2029) & (K Dose)
    Figure 10. China Microneedle Flu Vaccine Production (2018-2029) & (K Dose)
    Figure 11. Japan Microneedle Flu Vaccine Production (2018-2029) & (K Dose)
    Figure 12. Microneedle Flu Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 15. World Microneedle Flu Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 17. China Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 18. Europe Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 19. Japan Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 20. South Korea Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 21. ASEAN Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 22. India Microneedle Flu Vaccine Consumption (2018-2029) & (K Dose)
    Figure 23. Producer Shipments of Microneedle Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Microneedle Flu Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Microneedle Flu Vaccine Markets in 2022
    Figure 26. United States VS China: Microneedle Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Microneedle Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Microneedle Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Microneedle Flu Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Microneedle Flu Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Market Share 2022
    Figure 32. World Microneedle Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Microneedle Flu Vaccine Production Value Market Share by Type in 2022
    Figure 34. Solid Microneedle
    Figure 35. Hollow Microneedle
    Figure 36. Coated Microneedle
    Figure 37. Dissolving Microneedle
    Figure 38. World Microneedle Flu Vaccine Production Market Share by Type (2018-2029)
    Figure 39. World Microneedle Flu Vaccine Production Value Market Share by Type (2018-2029)
    Figure 40. World Microneedle Flu Vaccine Average Price by Type (2018-2029) & (US$/Dose)
    Figure 41. World Microneedle Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Microneedle Flu Vaccine Production Value Market Share by Application in 2022
    Figure 43. Influenza A
    Figure 44. Influenza B
    Figure 45. World Microneedle Flu Vaccine Production Market Share by Application (2018-2029)
    Figure 46. World Microneedle Flu Vaccine Production Value Market Share by Application (2018-2029)
    Figure 47. World Microneedle Flu Vaccine Average Price by Application (2018-2029) & (US$/Dose)
    Figure 48. Microneedle Flu Vaccine Industry Chain
    Figure 49. Microneedle Flu Vaccine Procurement Model
    Figure 50. Microneedle Flu Vaccine Sales Model
    Figure 51. Microneedle Flu Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies

Related Reports

Global Microneedle Flu Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Microneedle Flu Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 01 Apr 2021

date Pharma & Healthcare

The Microneedle Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Microneedle Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Microneedle Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022

date Pharma & Healthcare

Global Microneedle Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Microneedle Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.

Global Microneedle Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Microneedle Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Microneedle Flu Vaccine market size was valued at USD 1463.2 million in 2023 and is forecast to a readjusted size of USD 2095.3 million by 2030 with a CAGR of 5.3% during review period.

Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2024-2030

Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Microneedle Flu Vaccine market size is expected to reach $ 2095.3 million by 2030, rising at a market growth of 5.3% CAGR during the forecast period (2024-2030).

Product Tags

microneedle flu vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>